Albemarle (ALB) Is An Undervalued Chemical Play, PT to $86 at Baird
Tweet Send to a Friend
Baird analyst Ben Kallo lowered the price target on Albemarle (NYSE: ALB) to $86.00 (from $110.00) but maintained his Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
